ETON PHARMACEUTICALS INC (ETON)

US29772L1089 - Common Stock

3.62  -0.03 (-0.82%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 MRQ
(2024-3-31)		 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)
ASSETS
Current Assets
Cash Equivalents
16.66M21.39M16.31M14.41M21.30M
Receivables
4.24M3.41M1.85M5.47M50.00K
Inventories
2.32M911.00K560.00K550.00K1.24M
Other Current Assets
1.05M1.13M1.29M3.18M2.12M
Total Current Assets
24.26M26.84M20.00M23.60M24.70M
 
Non-Current Assets
PPE Net
131.00K150.00K260.00K220.00K1.00M
Intangibles
6.39M4.74M4.75M3.62M580.00K
Other Non-Current Assets
12.00K12.00K10.00K20.00K40.00K
Total Non-Current Assets
6.53M4.90M5.03M3.87M1.62M
 
TOTAL ASSETS
30.79M31.74M25.03M27.47M26.32M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Current Portion Of LT Debt.
5.02M5.38M1.03M1.42M280.00K
Accrued Expenses
8.02M9.01M3.74M1.37M1.17M
Accounts Payable
2.26M1.85M1.69M1.77M2.34M
Total Current Liabilities
15.30M16.24M6.46M4.56M3.79M
 
Non-Current Liabilities
Long Term Debt
0.000.005.38M5.26M6.76M
Other Non-Current Liabilities
0.0022.00K110.00K20.00K100.00K
Total Non-Current Liabilities
0.0022.00K5.49M5.28M6.87M
 
TOTAL LIABILITIES
15.30M16.26M11.95M9.84M10.66M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-104.88M-104.07M-103.13M-94.11M-92.16M
Additional Paid In Capital
120.35M119.52M116.19M111.72M107.80M
Common Shares
26.00K26.00K30.00K30.00K20.00K
Shares Outstanding
25.69M25.69M25.35M24.63M24.31M
Tangible Book Value per Share
0.350.420.330.570.62
Total Shareholders' Equity
15.49M15.48M13.08M17.63M15.66M
 
TOTAL LIABILITIES AND EQUITY
30.79M31.74M25.03M27.47M26.32M
 
Statistics
Debt/Equity
N/AN/A0.410.300.43
Current Ratio
1.591.653.105.186.52
Return On Assets (ROA)
2.96%-2.95%-36.04%-7.14%-106.27%
Return On Equity (ROE)
5.89%-6.05%-68.96%-11.12%-178.61%
Return On Invested Capital (ROIC)
2.74%N/AN/AN/AN/A

All data in USD

Charts